Volume 16, Number 7—July 2010
Mycobacterium conceptionense Infection after Breast Implant Surgery, France
|Patient age, y||Clinical situation||Identification||Treatment
|31||Posttraumatic osteitis||16S rRNA, soda, hsp65, recA, rpoB†||Antimicrobial drug therapy: AMC||3||(4)|
|43||Subcutaneous abscess without trauma||partial 1,464-bp 16S rRNA gene‡||Surgery and antimicrobial drug therapy: COT and CLA; then DOX and CLA; then LIN and CLA||5||(10)|
|58||Breast implant infection||rpoB§||Surgery and antimicrobial drug therapy: CIP and AZY; then CIP, AZY, and DOX; then DOX||18||This report|
*AMC, amoxicillin/clavulanic acid; COT, cotrimoxazole; CLA, clarithromycin; DOX, doxycycline; LIN, linezolid; CIP, ciprofloxacin, AZY, azythromycin. The outcome for all 3 patients was favorable.
†GenBank accession nos.: 16S rRNA, AY859684; rpoB, AY859695; hsp65, AY859678; sodA, AY859708; recA, AY859690.
‡GenBank accession no. AM884289.1.
§GenBank accession no. AY859695.1.
- Page created: March 02, 2011
- Page last updated: March 02, 2011
- Page last reviewed: March 02, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)